Respiratory Tract Infection Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug (Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, Others); Disease Indication (Upper Respiratory Tract Infection, Lower Respiratory Tract Infection); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography
Report Code: TIPRE00003835 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET OVERVIEW
Any infectious disease affecting the upper or lower respiratory tract is referred to as a respiratory tract infection (RTI). The common cold, laryngitis, pharyngitis/tonsillitis, acute rhinitis, acute rhinosinusitis, and acute otitis media are all upper respiratory tract infections (URTIs). Acute bronchitis, bronchiolitis, pneumonia, and tracheitis are examples of lower respiratory tract infections (LRTIs). In primary care, antibiotics are commonly prescribed for RTIs in adults and children.
MARKET SCOPE
The "Global Respiratory Tract Infection Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the respiratory tract infection treatment market with detailed market segmentation by drug, disease indication and distribution channel. The report provides key statistics on the market status of the leading respiratory tract infection treatment market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on drug the market is segmented as, antibiotics, non-steroidal anti-inflammatory drug (NSAIDS), cough suppressant, nasal decongestant, others.
- Based on disease indication the market is segmented as, upper respiratory tract infection, lower respiratory tract infection.
- Based on distribution channel the market is segmented as, hospital pharmacies, retail pharmacies, and online pharmacies.
MARKET DYNAMICS
Drivers:
- Increasing incidences of respiratory disorders and rising prevalence of allergic reactions are the key drivers for the market growth.
- Technological advancements in development of respiratory preparations and availability of medicines at lower costs.
- Presence of robust pipeline of agents to manage respiratory tract infections.
- Growing OTC product demand to treat respiratory infections.
Restraints:
- However, risk of possible side effects is expected to restrain the market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The respiratory tract infection treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the respiratory tract infection treatment market in these regions.
IMPACT OF COVID-19 ON RESPIRATORY TRACT INFECTION TREATMENT MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the respiratory tract infection treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from respiratory tract infection treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for respiratory tract infection treatment in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the respiratory tract infection treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abbott
- AstraZeneca
- Alembic Pharmaceuticals
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd
- Intas Pharmaceuticals Ltd.
- Novartis AG
- F. Hoffman La Roche Ltd
- Sanofi
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Respiratory Tract Infection Treatment Market - By Drug
1.3.2 Respiratory Tract Infection Treatment Market - By Disease Indication
1.3.3 Respiratory Tract Infection Treatment Market - By Distribution Channel
1.3.4 Respiratory Tract Infection Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RESPIRATORY TRACT INFECTION TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. RESPIRATORY TRACT INFECTION TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RESPIRATORY TRACT INFECTION TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. RESPIRATORY TRACT INFECTION TREATMENT - GLOBAL MARKET OVERVIEW
6.2. RESPIRATORY TRACT INFECTION TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RESPIRATORY TRACT INFECTION TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DRUG
7.1. OVERVIEW
7.2. DRUG MARKET FORECASTS AND ANALYSIS
7.3. ANTIBIOTICS
7.3.1. Overview
7.3.2. Antibiotics Market Forecast and Analysis
7.4. NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAIDS)
7.4.1. Overview
7.4.2. Non-Steroidal Anti-Inflammatory Drug (NSAIDS) Market Forecast and Analysis
7.5. COUGH SUPPRESSANT
7.5.1. Overview
7.5.2. Cough Suppressant Market Forecast and Analysis
7.6. NASAL DECONGESTANT
7.6.1. Overview
7.6.2. Nasal Decongestant Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. RESPIRATORY TRACT INFECTION TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE INDICATION
8.1. OVERVIEW
8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
8.3. UPPER RESPIRATORY TRACT INFECTION
8.3.1. Overview
8.3.2. Upper Respiratory Tract Infection Market Forecast and Analysis
8.4. LOWER RESPIRATORY TRACT INFECTION
8.4.1. Overview
8.4.2. Lower Respiratory Tract Infection Market Forecast and Analysis
9. RESPIRATORY TRACT INFECTION TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. RESPIRATORY TRACT INFECTION TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Respiratory Tract Infection Treatment Market Overview
10.1.2 North America Respiratory Tract Infection Treatment Market Forecasts and Analysis
10.1.3 North America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Drug
10.1.4 North America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Disease Indication
10.1.5 North America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Respiratory Tract Infection Treatment Market
10.1.6.1.1 United States Respiratory Tract Infection Treatment Market by Drug
10.1.6.1.2 United States Respiratory Tract Infection Treatment Market by Disease Indication
10.1.6.1.3 United States Respiratory Tract Infection Treatment Market by Distribution Channel
10.1.6.2 Canada Respiratory Tract Infection Treatment Market
10.1.6.2.1 Canada Respiratory Tract Infection Treatment Market by Drug
10.1.6.2.2 Canada Respiratory Tract Infection Treatment Market by Disease Indication
10.1.6.2.3 Canada Respiratory Tract Infection Treatment Market by Distribution Channel
10.1.6.3 Mexico Respiratory Tract Infection Treatment Market
10.1.6.3.1 Mexico Respiratory Tract Infection Treatment Market by Drug
10.1.6.3.2 Mexico Respiratory Tract Infection Treatment Market by Disease Indication
10.1.6.3.3 Mexico Respiratory Tract Infection Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Respiratory Tract Infection Treatment Market Overview
10.2.2 Europe Respiratory Tract Infection Treatment Market Forecasts and Analysis
10.2.3 Europe Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Drug
10.2.4 Europe Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Disease Indication
10.2.5 Europe Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Respiratory Tract Infection Treatment Market
10.2.6.1.1 Germany Respiratory Tract Infection Treatment Market by Drug
10.2.6.1.2 Germany Respiratory Tract Infection Treatment Market by Disease Indication
10.2.6.1.3 Germany Respiratory Tract Infection Treatment Market by Distribution Channel
10.2.6.2 France Respiratory Tract Infection Treatment Market
10.2.6.2.1 France Respiratory Tract Infection Treatment Market by Drug
10.2.6.2.2 France Respiratory Tract Infection Treatment Market by Disease Indication
10.2.6.2.3 France Respiratory Tract Infection Treatment Market by Distribution Channel
10.2.6.3 Italy Respiratory Tract Infection Treatment Market
10.2.6.3.1 Italy Respiratory Tract Infection Treatment Market by Drug
10.2.6.3.2 Italy Respiratory Tract Infection Treatment Market by Disease Indication
10.2.6.3.3 Italy Respiratory Tract Infection Treatment Market by Distribution Channel
10.2.6.4 Spain Respiratory Tract Infection Treatment Market
10.2.6.4.1 Spain Respiratory Tract Infection Treatment Market by Drug
10.2.6.4.2 Spain Respiratory Tract Infection Treatment Market by Disease Indication
10.2.6.4.3 Spain Respiratory Tract Infection Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Respiratory Tract Infection Treatment Market
10.2.6.5.1 United Kingdom Respiratory Tract Infection Treatment Market by Drug
10.2.6.5.2 United Kingdom Respiratory Tract Infection Treatment Market by Disease Indication
10.2.6.5.3 United Kingdom Respiratory Tract Infection Treatment Market by Distribution Channel
10.2.6.6 Rest of Europe Respiratory Tract Infection Treatment Market
10.2.6.6.1 Rest of Europe Respiratory Tract Infection Treatment Market by Drug
10.2.6.6.2 Rest of Europe Respiratory Tract Infection Treatment Market by Disease Indication
10.2.6.6.3 Rest of Europe Respiratory Tract Infection Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Respiratory Tract Infection Treatment Market Overview
10.3.2 Asia-Pacific Respiratory Tract Infection Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Drug
10.3.4 Asia-Pacific Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Disease Indication
10.3.5 Asia-Pacific Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Respiratory Tract Infection Treatment Market
10.3.6.1.1 Australia Respiratory Tract Infection Treatment Market by Drug
10.3.6.1.2 Australia Respiratory Tract Infection Treatment Market by Disease Indication
10.3.6.1.3 Australia Respiratory Tract Infection Treatment Market by Distribution Channel
10.3.6.2 China Respiratory Tract Infection Treatment Market
10.3.6.2.1 China Respiratory Tract Infection Treatment Market by Drug
10.3.6.2.2 China Respiratory Tract Infection Treatment Market by Disease Indication
10.3.6.2.3 China Respiratory Tract Infection Treatment Market by Distribution Channel
10.3.6.3 India Respiratory Tract Infection Treatment Market
10.3.6.3.1 India Respiratory Tract Infection Treatment Market by Drug
10.3.6.3.2 India Respiratory Tract Infection Treatment Market by Disease Indication
10.3.6.3.3 India Respiratory Tract Infection Treatment Market by Distribution Channel
10.3.6.4 Japan Respiratory Tract Infection Treatment Market
10.3.6.4.1 Japan Respiratory Tract Infection Treatment Market by Drug
10.3.6.4.2 Japan Respiratory Tract Infection Treatment Market by Disease Indication
10.3.6.4.3 Japan Respiratory Tract Infection Treatment Market by Distribution Channel
10.3.6.5 South Korea Respiratory Tract Infection Treatment Market
10.3.6.5.1 South Korea Respiratory Tract Infection Treatment Market by Drug
10.3.6.5.2 South Korea Respiratory Tract Infection Treatment Market by Disease Indication
10.3.6.5.3 South Korea Respiratory Tract Infection Treatment Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Respiratory Tract Infection Treatment Market
10.3.6.6.1 Rest of Asia-Pacific Respiratory Tract Infection Treatment Market by Drug
10.3.6.6.2 Rest of Asia-Pacific Respiratory Tract Infection Treatment Market by Disease Indication
10.3.6.6.3 Rest of Asia-Pacific Respiratory Tract Infection Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Respiratory Tract Infection Treatment Market Overview
10.4.2 Middle East and Africa Respiratory Tract Infection Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Drug
10.4.4 Middle East and Africa Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Disease Indication
10.4.5 Middle East and Africa Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Respiratory Tract Infection Treatment Market
10.4.6.1.1 South Africa Respiratory Tract Infection Treatment Market by Drug
10.4.6.1.2 South Africa Respiratory Tract Infection Treatment Market by Disease Indication
10.4.6.1.3 South Africa Respiratory Tract Infection Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Respiratory Tract Infection Treatment Market
10.4.6.2.1 Saudi Arabia Respiratory Tract Infection Treatment Market by Drug
10.4.6.2.2 Saudi Arabia Respiratory Tract Infection Treatment Market by Disease Indication
10.4.6.2.3 Saudi Arabia Respiratory Tract Infection Treatment Market by Distribution Channel
10.4.6.3 U.A.E Respiratory Tract Infection Treatment Market
10.4.6.3.1 U.A.E Respiratory Tract Infection Treatment Market by Drug
10.4.6.3.2 U.A.E Respiratory Tract Infection Treatment Market by Disease Indication
10.4.6.3.3 U.A.E Respiratory Tract Infection Treatment Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market
10.4.6.4.1 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market by Drug
10.4.6.4.2 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market by Disease Indication
10.4.6.4.3 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Respiratory Tract Infection Treatment Market Overview
10.5.2 South and Central America Respiratory Tract Infection Treatment Market Forecasts and Analysis
10.5.3 South and Central America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Drug
10.5.4 South and Central America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Disease Indication
10.5.5 South and Central America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Respiratory Tract Infection Treatment Market
10.5.6.1.1 Brazil Respiratory Tract Infection Treatment Market by Drug
10.5.6.1.2 Brazil Respiratory Tract Infection Treatment Market by Disease Indication
10.5.6.1.3 Brazil Respiratory Tract Infection Treatment Market by Distribution Channel
10.5.6.2 Argentina Respiratory Tract Infection Treatment Market
10.5.6.2.1 Argentina Respiratory Tract Infection Treatment Market by Drug
10.5.6.2.2 Argentina Respiratory Tract Infection Treatment Market by Disease Indication
10.5.6.2.3 Argentina Respiratory Tract Infection Treatment Market by Distribution Channel
10.5.6.3 Rest of South and Central America Respiratory Tract Infection Treatment Market
10.5.6.3.1 Rest of South and Central America Respiratory Tract Infection Treatment Market by Drug
10.5.6.3.2 Rest of South and Central America Respiratory Tract Infection Treatment Market by Disease Indication
10.5.6.3.3 Rest of South and Central America Respiratory Tract Infection Treatment Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. RESPIRATORY TRACT INFECTION TREATMENT MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTRAZENECA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ALEMBIC PHARMACEUTICALS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLAXOSMITHKLINE PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. TEVA PHARMACEUTICAL INDUSTRIES LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. INTAS PHARMACEUTICALS LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. F. HOFFMAN LA ROCHE LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SANOFI
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
"
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Respiratory Tract Infection Treatment Market - By Drug
1.3.2 Respiratory Tract Infection Treatment Market - By Disease Indication
1.3.3 Respiratory Tract Infection Treatment Market - By Distribution Channel
1.3.4 Respiratory Tract Infection Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RESPIRATORY TRACT INFECTION TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. RESPIRATORY TRACT INFECTION TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RESPIRATORY TRACT INFECTION TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. RESPIRATORY TRACT INFECTION TREATMENT - GLOBAL MARKET OVERVIEW
6.2. RESPIRATORY TRACT INFECTION TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RESPIRATORY TRACT INFECTION TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DRUG
7.1. OVERVIEW
7.2. DRUG MARKET FORECASTS AND ANALYSIS
7.3. ANTIBIOTICS
7.3.1. Overview
7.3.2. Antibiotics Market Forecast and Analysis
7.4. NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAIDS)
7.4.1. Overview
7.4.2. Non-Steroidal Anti-Inflammatory Drug (NSAIDS) Market Forecast and Analysis
7.5. COUGH SUPPRESSANT
7.5.1. Overview
7.5.2. Cough Suppressant Market Forecast and Analysis
7.6. NASAL DECONGESTANT
7.6.1. Overview
7.6.2. Nasal Decongestant Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. RESPIRATORY TRACT INFECTION TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE INDICATION
8.1. OVERVIEW
8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
8.3. UPPER RESPIRATORY TRACT INFECTION
8.3.1. Overview
8.3.2. Upper Respiratory Tract Infection Market Forecast and Analysis
8.4. LOWER RESPIRATORY TRACT INFECTION
8.4.1. Overview
8.4.2. Lower Respiratory Tract Infection Market Forecast and Analysis
9. RESPIRATORY TRACT INFECTION TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. RESPIRATORY TRACT INFECTION TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Respiratory Tract Infection Treatment Market Overview
10.1.2 North America Respiratory Tract Infection Treatment Market Forecasts and Analysis
10.1.3 North America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Drug
10.1.4 North America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Disease Indication
10.1.5 North America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Respiratory Tract Infection Treatment Market
10.1.6.1.1 United States Respiratory Tract Infection Treatment Market by Drug
10.1.6.1.2 United States Respiratory Tract Infection Treatment Market by Disease Indication
10.1.6.1.3 United States Respiratory Tract Infection Treatment Market by Distribution Channel
10.1.6.2 Canada Respiratory Tract Infection Treatment Market
10.1.6.2.1 Canada Respiratory Tract Infection Treatment Market by Drug
10.1.6.2.2 Canada Respiratory Tract Infection Treatment Market by Disease Indication
10.1.6.2.3 Canada Respiratory Tract Infection Treatment Market by Distribution Channel
10.1.6.3 Mexico Respiratory Tract Infection Treatment Market
10.1.6.3.1 Mexico Respiratory Tract Infection Treatment Market by Drug
10.1.6.3.2 Mexico Respiratory Tract Infection Treatment Market by Disease Indication
10.1.6.3.3 Mexico Respiratory Tract Infection Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Respiratory Tract Infection Treatment Market Overview
10.2.2 Europe Respiratory Tract Infection Treatment Market Forecasts and Analysis
10.2.3 Europe Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Drug
10.2.4 Europe Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Disease Indication
10.2.5 Europe Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Respiratory Tract Infection Treatment Market
10.2.6.1.1 Germany Respiratory Tract Infection Treatment Market by Drug
10.2.6.1.2 Germany Respiratory Tract Infection Treatment Market by Disease Indication
10.2.6.1.3 Germany Respiratory Tract Infection Treatment Market by Distribution Channel
10.2.6.2 France Respiratory Tract Infection Treatment Market
10.2.6.2.1 France Respiratory Tract Infection Treatment Market by Drug
10.2.6.2.2 France Respiratory Tract Infection Treatment Market by Disease Indication
10.2.6.2.3 France Respiratory Tract Infection Treatment Market by Distribution Channel
10.2.6.3 Italy Respiratory Tract Infection Treatment Market
10.2.6.3.1 Italy Respiratory Tract Infection Treatment Market by Drug
10.2.6.3.2 Italy Respiratory Tract Infection Treatment Market by Disease Indication
10.2.6.3.3 Italy Respiratory Tract Infection Treatment Market by Distribution Channel
10.2.6.4 Spain Respiratory Tract Infection Treatment Market
10.2.6.4.1 Spain Respiratory Tract Infection Treatment Market by Drug
10.2.6.4.2 Spain Respiratory Tract Infection Treatment Market by Disease Indication
10.2.6.4.3 Spain Respiratory Tract Infection Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Respiratory Tract Infection Treatment Market
10.2.6.5.1 United Kingdom Respiratory Tract Infection Treatment Market by Drug
10.2.6.5.2 United Kingdom Respiratory Tract Infection Treatment Market by Disease Indication
10.2.6.5.3 United Kingdom Respiratory Tract Infection Treatment Market by Distribution Channel
10.2.6.6 Rest of Europe Respiratory Tract Infection Treatment Market
10.2.6.6.1 Rest of Europe Respiratory Tract Infection Treatment Market by Drug
10.2.6.6.2 Rest of Europe Respiratory Tract Infection Treatment Market by Disease Indication
10.2.6.6.3 Rest of Europe Respiratory Tract Infection Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Respiratory Tract Infection Treatment Market Overview
10.3.2 Asia-Pacific Respiratory Tract Infection Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Drug
10.3.4 Asia-Pacific Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Disease Indication
10.3.5 Asia-Pacific Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Respiratory Tract Infection Treatment Market
10.3.6.1.1 Australia Respiratory Tract Infection Treatment Market by Drug
10.3.6.1.2 Australia Respiratory Tract Infection Treatment Market by Disease Indication
10.3.6.1.3 Australia Respiratory Tract Infection Treatment Market by Distribution Channel
10.3.6.2 China Respiratory Tract Infection Treatment Market
10.3.6.2.1 China Respiratory Tract Infection Treatment Market by Drug
10.3.6.2.2 China Respiratory Tract Infection Treatment Market by Disease Indication
10.3.6.2.3 China Respiratory Tract Infection Treatment Market by Distribution Channel
10.3.6.3 India Respiratory Tract Infection Treatment Market
10.3.6.3.1 India Respiratory Tract Infection Treatment Market by Drug
10.3.6.3.2 India Respiratory Tract Infection Treatment Market by Disease Indication
10.3.6.3.3 India Respiratory Tract Infection Treatment Market by Distribution Channel
10.3.6.4 Japan Respiratory Tract Infection Treatment Market
10.3.6.4.1 Japan Respiratory Tract Infection Treatment Market by Drug
10.3.6.4.2 Japan Respiratory Tract Infection Treatment Market by Disease Indication
10.3.6.4.3 Japan Respiratory Tract Infection Treatment Market by Distribution Channel
10.3.6.5 South Korea Respiratory Tract Infection Treatment Market
10.3.6.5.1 South Korea Respiratory Tract Infection Treatment Market by Drug
10.3.6.5.2 South Korea Respiratory Tract Infection Treatment Market by Disease Indication
10.3.6.5.3 South Korea Respiratory Tract Infection Treatment Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Respiratory Tract Infection Treatment Market
10.3.6.6.1 Rest of Asia-Pacific Respiratory Tract Infection Treatment Market by Drug
10.3.6.6.2 Rest of Asia-Pacific Respiratory Tract Infection Treatment Market by Disease Indication
10.3.6.6.3 Rest of Asia-Pacific Respiratory Tract Infection Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Respiratory Tract Infection Treatment Market Overview
10.4.2 Middle East and Africa Respiratory Tract Infection Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Drug
10.4.4 Middle East and Africa Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Disease Indication
10.4.5 Middle East and Africa Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Respiratory Tract Infection Treatment Market
10.4.6.1.1 South Africa Respiratory Tract Infection Treatment Market by Drug
10.4.6.1.2 South Africa Respiratory Tract Infection Treatment Market by Disease Indication
10.4.6.1.3 South Africa Respiratory Tract Infection Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Respiratory Tract Infection Treatment Market
10.4.6.2.1 Saudi Arabia Respiratory Tract Infection Treatment Market by Drug
10.4.6.2.2 Saudi Arabia Respiratory Tract Infection Treatment Market by Disease Indication
10.4.6.2.3 Saudi Arabia Respiratory Tract Infection Treatment Market by Distribution Channel
10.4.6.3 U.A.E Respiratory Tract Infection Treatment Market
10.4.6.3.1 U.A.E Respiratory Tract Infection Treatment Market by Drug
10.4.6.3.2 U.A.E Respiratory Tract Infection Treatment Market by Disease Indication
10.4.6.3.3 U.A.E Respiratory Tract Infection Treatment Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market
10.4.6.4.1 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market by Drug
10.4.6.4.2 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market by Disease Indication
10.4.6.4.3 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Respiratory Tract Infection Treatment Market Overview
10.5.2 South and Central America Respiratory Tract Infection Treatment Market Forecasts and Analysis
10.5.3 South and Central America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Drug
10.5.4 South and Central America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Disease Indication
10.5.5 South and Central America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Respiratory Tract Infection Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Respiratory Tract Infection Treatment Market
10.5.6.1.1 Brazil Respiratory Tract Infection Treatment Market by Drug
10.5.6.1.2 Brazil Respiratory Tract Infection Treatment Market by Disease Indication
10.5.6.1.3 Brazil Respiratory Tract Infection Treatment Market by Distribution Channel
10.5.6.2 Argentina Respiratory Tract Infection Treatment Market
10.5.6.2.1 Argentina Respiratory Tract Infection Treatment Market by Drug
10.5.6.2.2 Argentina Respiratory Tract Infection Treatment Market by Disease Indication
10.5.6.2.3 Argentina Respiratory Tract Infection Treatment Market by Distribution Channel
10.5.6.3 Rest of South and Central America Respiratory Tract Infection Treatment Market
10.5.6.3.1 Rest of South and Central America Respiratory Tract Infection Treatment Market by Drug
10.5.6.3.2 Rest of South and Central America Respiratory Tract Infection Treatment Market by Disease Indication
10.5.6.3.3 Rest of South and Central America Respiratory Tract Infection Treatment Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. RESPIRATORY TRACT INFECTION TREATMENT MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTRAZENECA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ALEMBIC PHARMACEUTICALS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLAXOSMITHKLINE PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. TEVA PHARMACEUTICAL INDUSTRIES LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. INTAS PHARMACEUTICALS LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. F. HOFFMAN LA ROCHE LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SANOFI
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
"
The List of Companies
- Abbott
- AstraZeneca
- Alembic Pharmaceuticals
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd
- Intas Pharmaceuticals Ltd.
- Novartis AG
- F. Hoffman La Roche Ltd
- Sanofi
- Procter and Gamble
- Cipla Inc
- Dr. Reddy's Laboratories
- Johnson and Johnson Private Limited
- Bayer
- Abbott
- AstraZeneca
- Alembic Pharmaceuticals
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd
- Intas Pharmaceuticals Ltd.
- Novartis AG
- F. Hoffman La Roche Ltd
- Sanofi
- Procter and Gamble
- Cipla Inc
- Dr. Reddy's Laboratories
- Johnson and Johnson Private Limited
- Bayer
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
GET FREE SAMPLE PDF
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount